Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation

Molecular and Cellular Biology

Volumn 23, Issue 7, 2003, Pages 2425-2437

  Du, Kevin L ^a   Ip, Hon S ^b   Li, Jian ^a   Chen, Mary ^a   Dandre, Frederic ^c   Yu, William ^a   Lu, Min Min ^a   Owens, Gary K ^c   Parmacek, Michael S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Third Wave Technologies Inc   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CALPONIN; MYOCARDIN; RNA; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE MAPPING; HEART DEVELOPMENT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; STEM CELL; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COS CELLS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RATS; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; SERUM RESPONSE FACTOR; STEM CELLS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ANIMALIA; MURINAE;

EID: 0037379178     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.7.2425-2437.2003     Document Type: Article

References (50)

1. Aravind, L., and E. V. Koonin. 2000. SAP - a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112-114.
2. Arsenian, S., B. Weinbold, M. Oelgeschlager, U. Ruther, and A. Nordheim. 1998. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:6289-6299.
3. Belaguli, N. S., W. Zhou, T.-H. T. Trinh, M. W. Majesky, and R. J. Schwartz. 1999. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol. Cell. Biol. 19:4582-4591.
4. Chang, P. S., L. Li, J. McAnally, and E. N. Olson. 2001. Muscle specificity encoded by specific serum response factor-binding sites. J. Biol. Chem. 276:17206-17212.
5. Chen, C. Y., and R. J. Schwartz. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol. 16:6372-6384.
6. Doetschman, T. C., H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27-45.
7. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
8. Garrard, W. T. 1990. Chromosomal loop organization in eukaryotic genomes, p. 163-176. In D. J. M. Lilley (ed.), Nucleic acids and molecular biology. Spinger-Verlag, Heidelberg, Germany.
9. Gohring, F., and F. O. Fackelmayer. 1997. The scaffold/matrix attachment region binding protein hnRNP-U (SAF-1) is directly bound to chromosomal DNA in vivo: a chemical cross-linking study. Biochemistry 36:8267-8283.
10. Gohring, F., B. L. Schwab, P. Nicotera, M. Leist, and F. O. Fackelmayer. 1997. The novel SAR-binding domain of scaffold attachment factor a (SAF-A) is a target in apoptotic nuclear breakdown. EMBO J. 16:7361-7371.
11. Grueneberg, D. A., S. Natesan, C. Alexandre, and M. Z. Gilman. 1992. Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science 257:1089-1095.
12. Herring, B. P., and A. F. Smith. 1997. Telokin expression in A10 smooth muscle cells requires serum response factor. Am. J. Physiol. 272:C1394-C1404.
13. Hill, C. S., J. Wynne, and R. Treisman. 1994. Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J. 13:5421-5432.
14. James, A. L., P. D. Pare, and J. C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:242-246.
15. Jenuwein, T., W. C. Forrester, L. A. Fernandez-Herrero, G. Laible, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385:269-272.
16. Johansen, F. E., and R. Prywes. 1993. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by with GALA-SRF constructs. Mol. Cell. Biol. 13:4640-4647.
17. Kemp, P. R., and J. C. Metcalfe. 2000. Four isoforms of serum response factor that activate or inhibit smooth muscle-specific promoter activity. Biochem. J. 345:445-451.
18. Kiledjian, M., and G. Dreyfuss. 1992. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 11:2655-2664.
19. Kim, S., H. S. Ip, M. M. Lu, C. Clendenin, and M. S. Parmacek. 1997. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol. Cell. Biol. 17:2266-2278.
20. Kipp, M., F. Gohring, T. Ostendorp, C. M. van Drunen, R. van Driel, M. Przybylski, and F. O. Fackelmayer. 2000. SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA. Mol. Cell. Biol. 20:7480-7489.
21. Laemmli, U. K., E. Kas, L. Poljak, and Y. Adachi. 1992. Scaffold associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev. 2:275-285.
22. Landerholm, T. E., X.-R. Dong, N. S. Belaguli, R. J. Schwartz, and M. W. Majesky. 1999. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development 126:1053-2062.
23. Li, L., J. M. Miano, P. Cserjesi, and E. N. Olson. 1996. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
24. Li, L., J. M. Miano, B. Mercer, and E. N. Olson. 1996. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:849-859.
25. Mack, C. P., and G. K. Owens. 1999. Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ. Res. 84:852-861.
26. Madsen, C. S., C. P. Regan, J. E. Hungerford, S. L. White, I. Manabe, and G. K. Owens. 1998. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ. Res. 82:908-917.
27. Mirkovitch, J., M. E. Mirault, and U. K. Laemmli. 1984. Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39:223-232.
28. Moessler, H., M. Merieskay, Z. Li, S. Nagl, D. Paulin, and J. V. Small. 1996. The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122:2415-2425.
29. Morrisey, E. E., H. S. Ip, M. M. Lu, and M. S. Parmacek. 1996. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev. Biol. 177:309-322.
30. Morrisey, E. E., H. S. Ip, Z. Tang, and M. S. Parmacek. 1997. GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J. Biol. Chem. 272:8515-8524.
31. Morrisey, E. E., Z. Tang, K. Sigrist, M. M. Lu, F. Jiang, H. S. Ip, and M. S. Parmacek. 1998. GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev. 12:3579-3590.
32. Mortensen, R. M., D. A. Conner, S. Chao, A. A. T. Geisterfer-Lowrance, and J. G. Seidman. 1992. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12:2391-2395.
33. Newby, A. C., and A. B. Zaltsman. 1999. Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 41:345-360.
34. Osbourn, J. K., P. L. Weissberg, and C. M. Shanahan. 1995. A regulatory element downstream of the rat SM22α gene transcription start point enhances reporter gene expression in vascular smooth muscle cells. Gene 154:249-253.
35. Owens, G. K. 1998. Molecular control of vascular smooth muscle cell differentiation. Acta Physiol. Scand. 164:623-635.
36. Parmacek, M. S. 2001. Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr. Top. Dev. Biol. 51:69-89.
37. Parmacek, M. S., and J. M. Leiden. 1989. Structure and expression of the murine slow/cardiac troponin C gene. J. Biol. Chem. 264:13217-13225.
38. Qian, J., A. Kumar, J. C. Szuscik, and J. L. Lessard. 1996. Tissue and developmental specific expression of murine smooth muscle γ-actin fusion genes in transgenic mice. Dev. Dynam. 207:135-144.
39. Ross, R. 1999. Mechanisms of disease: atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
40. Sartorelli, V., K. A. Webster, and L. Kedes. 1990. Muscle-specific expression of the cardiac α-actin gene requires MyoD1, CArG-box binding factor, and Spl. Genes Dev. 4:1811-1822.
41. Schwartz, S. M., and C. E. Murry. 1998. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49:437-460.
42. Solway, J., J. Seltzer, F. F. Samaha, S. Kim, L. E. Alger, Q. Niu, E. E. Morrisey, H. S. Ip, and M. S. Parmacek. 1995. Structure and expression of a smooth muscle cell-specific gene SM22α. J. Biol. Chem. 270:13460-13469.
43. Stoneking, M., J. J. Fontius, S. L. Clifford, H. Soodyall, S. S. Arcot, N. Saha, T. Jenkins, M. A. Tahir, P. L. Deininger, and M. A. Batzer. 1997. Alu insertion polymorphisms and human evolution: evidence for a larger population size in Africa. Genome Res. 7:1061-1071.
44. Strobeck, M., S. Kim, J. C. Zhang, C. Clendenin, K. L. Du, and M. S. Parmacek. 2001. Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J. Biol. Chem. 276:16418-16424.
45. Treisman, R. 1995. DNA-binding proteins. Inside the MADS box. Nature 376:468-469.
46. Tsutsul, K., S. Okada, S. Watarai, S. Seki, T. Yasuda, and T. Shohmori. 1993. Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA. J. Biol. Chem. 268:12886-12894.
47. Tybulewicz, V. L. J., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.
48. Wang, D., P. S. Chang, Z. Wang, L. Sutherland, J. A. Richardson, E. Small, P. A. Krieg, and E. N. Olson. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105:851-862.
49. Wang, D., S. Li, D. Hockemeyer, L. Sutherland, Z. Wang, G. Schratt, J. A. Richardson, A. Nordheim, and E. N. Olson. 2002. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. USA 99:14855-14860.
50. Zhang, J. C., S. Kim, B. P. Helmke, W. W. Yu, K. L. Du, M. M. Lu, M. Strobeck, Q. Yu, and M. S. Parmacek. 2001. Analysis of SM22α-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol. Cell. Biol. 21:1336-1344.